Joanna Kałafut

Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer

Justyna Magdalena Hermanowicz, Anna Szymanowska, Beata Sieklucka et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 30 citations · Full text

Anticancer effects of sodium and potassium quercetin-5′-sulfonates through inhibition of proliferation, induction of apoptosis, and cell cycle arrest in the HT-29 human adenocarcinoma cell line

Arkadiusz Czerwonka, Urszula Maciołek, Joanna Kałafut et al. · Bioorganic Chemistry · 2019 · 24 citations

Oncology, Chemoprevention Strategy, Medicine +11

Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis

Anna Wawruszak, Jarogniew J. Łuszczki, Joanna Kałafut et al. · International Journal of Molecular Sciences · 2019 · 23 citations · Full text

Additive Pharmacological Interaction, Breast Oncology, Chemoprevention Strategy +17

Optogenetic control of NOTCH1 signaling

Joanna Kałafut, Jakub Czapiński, Alicja Przybyszewska-Podstawka et al. · Cell Communication and Signaling · 2022 · 17 citations · Full text

New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells

Iwona Rzeszutek, Martyna Cybularczyk‐Cecotka, Anna Deręgowska et al. · Journal of Medicinal Chemistry · 2024 · 16 citations · Full text